Safety and Efficacy of Etanercept in Patients With Psoriasis
Status:
Active, not recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety and efficacy of etanercept in patients with
psoriasis who had an unsatisfactory response to traditional DMARDs.